YSPSAH (7178): Results for Last 10 Financial Years (Summary)

Y.S.P.SOUTHEAST ASIA HOLDING

KLSE (MYR): YSPSAH (7178)

Live Data: OFF

You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!

Last Price

2.30

Today's Change

-0.03 (1.29%)

Day's Change

2.30 - 2.33

Trading Volume

29,100

Financial

Market Cap

326 Million

NOSH

142 Million

Latest Quarter

30-Sep-2024 [#3]

Announcement Date

22-Nov-2024

Next Quarter

31-Dec-2024

Est. Ann. Date

27-Feb-2025

Est. Ann. Due Date

01-Mar-2025

QoQ | YoY

8.53% | -41.90%

Revenue | NP to SH

361,235.000 | 28,649.000

RPS | P/RPS

254.67 Cent | 0.90

EPS | P/E | EY

20.20 Cent | 11.39 | 8.78%

DPS | DY | Payout %

11.00 Cent | 4.78% | 54.46%

NAPS | P/NAPS

2.84 | 0.81

QoQ | YoY

-8.04% | -18.08%

NP Margin | ROE

8.01% | 7.11%

F.Y. | Ann. Date

30-Sep-2024 | 22-Nov-2024

Latest Audited Result

31-Dec-2023

Announcement Date

23-Apr-2024

Next Audited Result

31-Dec-2024

Est. Ann. Date

23-Apr-2025

Est. Ann. Due Date

29-Jun-2025

Revenue | NP to SH

354,995.000 | 37,315.000

RPS | P/RPS

250.27 Cent | 0.92

EPS | P/E | EY

26.31 Cent | 8.74 | 11.44%

DPS | DY | Payout %

10.00 Cent | 4.35% | 38.01%

NAPS | P/NAPS

2.79 | 0.82

YoY

8.27%

NP Margin | ROE

10.66% | 9.43%

F.Y. | Ann. Date

31-Dec-2023 | 27-Feb-2024

Revenue | NP to SH

362,542.666 | 27,340.000

RPS | P/RPS

255.59 Cent | 0.90

EPS | P/E | EY

19.28 Cent | 11.93 | 8.38%

DPS | DY | Payout %

NAPS | P/NAPS

QoQ | YoY

-19.74% | -29.71%

NP Margin | ROE

7.65% | 6.79%

F.Y. | Ann. Date

30-Sep-2024 | 22-Nov-2024

Show?

YoY %

Horiz. %

	AQR	T4Q	31/12/23	31/12/22	31/12/21	31/12/20	31/12/19	31/12/18	31/12/17	31/12/16	31/12/15	31/12/14	CAGR
Last 10 FY Result
Revenue	362,542	361,235	354,995	334,248	281,860	297,061	295,619	288,759	261,556	237,065	222,925	202,226	6.44%
YoY %	0.36%	1.76%	6.21%	18.59%	-5.12%	0.49%	2.38%	10.40%	10.33%	6.34%	10.24%	-	-
Horiz. %	179.28%	178.63%	175.54%	165.28%	139.38%	146.90%	146.18%	142.79%	129.34%	117.23%	110.24%	100.00%	-
PBT	39,240	41,723	53,822	47,693	22,493	30,263	31,832	42,304	29,688	36,317	39,527	25,230	8.77%
YoY %	-5.95%	-22.48%	12.85%	112.03%	-25.67%	-4.93%	-24.75%	42.50%	-18.25%	-8.12%	56.67%	-	-
Horiz. %	155.53%	165.37%	213.33%	189.03%	89.15%	119.95%	126.17%	167.67%	117.67%	143.94%	156.67%	100.00%	-
Tax	-11,501	-12,774	-15,997	-12,920	-7,392	-8,104	-9,354	-12,171	-9,624	-8,399	-10,154	-8,139	7.79%
YoY %	9.97%	20.15%	-23.82%	-74.78%	8.79%	13.36%	23.15%	-26.47%	-14.59%	17.28%	-24.76%	-	-
Horiz. %	141.31%	156.95%	196.55%	158.74%	90.82%	99.57%	114.93%	149.54%	118.25%	103.19%	124.76%	100.00%	-
NP	27,738	28,949	37,825	34,773	15,101	22,159	22,478	30,133	20,064	27,918	29,373	17,091	9.22%
YoY %	-4.18%	-23.47%	8.78%	130.27%	-31.85%	-1.42%	-25.40%	50.18%	-28.13%	-4.95%	71.86%	-	-
Horiz. %	162.30%	169.38%	221.32%	203.46%	88.36%	129.65%	131.52%	176.31%	117.40%	163.35%	171.86%	100.00%	-
													-
YoY %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	-
Horiz. %	-	-	-	-	-	-	-	-	-	-	-	-	-
NP to SH	27,340	28,649	37,315	34,466	15,182	21,976	23,012	30,350	20,382	27,594	28,968	16,492	9.49%
YoY %	-4.57%	-23.22%	8.27%	127.02%	-30.92%	-4.50%	-24.18%	48.91%	-26.14%	-4.74%	75.65%	-	-
Horiz. %	165.78%	173.71%	226.26%	208.99%	92.06%	133.25%	139.53%	184.03%	123.59%	167.32%	175.65%	100.00%	-
													-
YoY %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	-
Horiz. %	-	-	-	-	-	-	-	-	-	-	-	-	-
Tax Rate	29.31%	30.62%	29.72%	27.09%	32.86%	26.78%	29.39%	28.77%	32.42%	23.13%	25.69%	32.26%	-
YoY %	-4.28%	3.03%	9.71%	-17.56%	22.70%	-8.88%	2.16%	-11.26%	40.16%	-9.96%	-20.37%	-	-
Horiz. %	90.86%	94.92%	92.13%	83.97%	101.86%	83.01%	91.10%	89.18%	100.50%	71.70%	79.63%	100.00%	-
Total Cost	334,804	332,286	317,170	299,475	266,759	274,902	273,141	258,626	241,492	209,147	193,552	185,135	6.16%
YoY %	0.76%	4.77%	5.91%	12.26%	-2.96%	0.64%	5.61%	7.10%	15.47%	8.06%	4.55%	-	-
Horiz. %	180.84%	179.48%	171.32%	161.76%	144.09%	148.49%	147.54%	139.70%	130.44%	112.97%	104.55%	100.00%	-
													-
YoY %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	-
Horiz. %	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Worth	402,839	402,839	395,691	372,290	343,721	341,901	328,027	315,262	289,871	274,727	256,898	235,410	5.93%
YoY %	0.00%	1.81%	6.29%	8.31%	0.53%	4.23%	4.05%	8.76%	5.51%	6.94%	9.13%	-	-
Horiz. %	171.12%	171.12%	168.09%	158.15%	146.01%	145.24%	139.34%	133.92%	123.13%	116.70%	109.13%	100.00%	-

	AQR	T4Q	31/12/23	31/12/22	31/12/21	31/12/20	31/12/19	31/12/18	31/12/17	31/12/16	31/12/15	31/12/14	CAGR
Dividend
Div	20,803	15,602	14,182	11,281	11,177	11,256	11,864	9,679	11,622	10,773	8,697	8,645	5.65%
YoY %	33.34%	10.01%	25.72%	0.93%	-0.70%	-5.12%	22.57%	-16.72%	7.88%	23.87%	0.60%	-	-
Horiz. %	240.64%	180.47%	164.05%	130.49%	129.29%	130.20%	137.24%	111.96%	134.44%	124.62%	100.60%	100.00%	-
Div Payout %	76.09%	54.46%	38.01%	32.73%	73.63%	51.22%	51.56%	31.89%	57.02%	39.04%	30.02%	52.42%	-
YoY %	39.72%	43.28%	16.13%	-55.55%	43.75%	-0.66%	61.68%	-44.07%	46.06%	30.05%	-42.73%	-	-
Horiz. %	145.15%	103.89%	72.51%	62.44%	140.46%	97.71%	98.36%	60.84%	108.78%	74.48%	57.27%	100.00%	-

	AQR	T4Q	31/12/23	31/12/22	31/12/21	31/12/20	31/12/19	31/12/18	31/12/17	31/12/16	31/12/15	31/12/14	CAGR
Equity
Net Worth	402,839	402,839	395,691	372,290	343,721	341,901	328,027	315,262	289,871	274,727	256,898	235,410	5.93%
YoY %	0.00%	1.81%	6.29%	8.31%	0.53%	4.23%	4.05%	8.76%	5.51%	6.94%	9.13%	-	-
Horiz. %	171.12%	171.12%	168.09%	158.15%	146.01%	145.24%	139.34%	133.92%	123.13%	116.70%	109.13%	100.00%	-
NOSH	141,844	141,844	141,844	141,034	140,899	140,700	139,583	138,301	136,746	134,670	133,801	133,000	0.71%
YoY %	0.00%	0.00%	0.57%	0.10%	0.14%	0.80%	0.93%	1.14%	1.54%	0.65%	0.60%	-	-
Horiz. %	106.65%	106.65%	106.65%	106.04%	105.94%	105.79%	104.95%	103.99%	102.82%	101.26%	100.60%	100.00%	-

	AQR	T4Q	31/12/23	31/12/22	31/12/21	31/12/20	31/12/19	31/12/18	31/12/17	31/12/16	31/12/15	31/12/14	CAGR
Ratio Analysis
NP Margin	7.65%	8.01%	10.66%	10.40%	5.36%	7.46%	7.60%	10.44%	7.67%	11.78%	13.18%	8.45%	-
YoY %	-4.49%	-24.86%	2.50%	94.03%	-28.15%	-1.84%	-27.20%	36.11%	-34.89%	-10.62%	55.98%	-	-
Horiz. %	90.53%	94.79%	126.15%	123.08%	63.43%	88.28%	89.94%	123.55%	90.77%	139.41%	155.98%	100.00%	-
ROE	6.79%	7.11%	9.43%	9.26%	4.42%	6.43%	7.02%	9.63%	7.03%	10.04%	11.28%	7.01%	-
YoY %	-4.50%	-24.60%	1.84%	109.50%	-31.26%	-8.40%	-27.10%	36.98%	-29.98%	-10.99%	60.91%	-	-
Horiz. %	96.86%	101.43%	134.52%	132.10%	63.05%	91.73%	100.14%	137.38%	100.29%	143.22%	160.91%	100.00%	-

	AQR	T4Q	31/12/23	31/12/22	31/12/21	31/12/20	31/12/19	31/12/18	31/12/17	31/12/16	31/12/15	31/12/14	CAGR
Per Share
RPS	255.59	254.67	250.30	237.02	201.73	211.13	211.78	208.83	191.29	176.03	166.61	152.05	5.69%
YoY %	0.36%	1.75%	5.60%	17.49%	-4.45%	-0.31%	1.41%	9.17%	8.67%	5.65%	9.58%	-	-
Horiz. %	168.10%	167.49%	164.62%	155.88%	132.67%	138.86%	139.28%	137.34%	125.81%	115.77%	109.58%	100.00%	-
EPS	19.28	20.20	26.37	24.45	10.87	15.68	16.54	22.05	15.01	20.49	21.65	12.40	8.73%
YoY %	-4.55%	-23.40%	7.85%	124.93%	-30.68%	-5.20%	-24.99%	46.90%	-26.74%	-5.36%	74.60%	-	-
Horiz. %	155.48%	162.90%	212.66%	197.18%	87.66%	126.45%	133.39%	177.82%	121.05%	165.24%	174.60%	100.00%	-
DPS	14.67	11.00	10.00	8.00	8.00	8.00	8.50	7.00	8.50	8.00	6.50	6.50	4.89%
YoY %	33.36%	10.00%	25.00%	0.00%	0.00%	-5.88%	21.43%	-17.65%	6.25%	23.08%	0.00%	-	-
Horiz. %	225.69%	169.23%	153.85%	123.08%	123.08%	123.08%	130.77%	107.69%	130.77%	123.08%	100.00%	100.00%	-
NAPS	2.84	2.84	2.79	2.64	2.46	2.43	2.35	2.28	2.12	2.04	1.92	1.77	5.18%
YoY %	0.00%	1.79%	5.68%	7.32%	1.23%	3.40%	3.07%	7.55%	3.92%	6.25%	8.47%	-	-
Horiz. %	160.45%	160.45%	157.63%	149.15%	138.98%	137.29%	132.77%	128.81%	119.77%	115.25%	108.47%	100.00%	-

	AQR	T4Q	31/12/23	31/12/22	31/12/21	31/12/20	31/12/19	31/12/18	31/12/17	31/12/16	31/12/15	31/12/14	CAGR
Adjusted Per Share Value based on latest NOSH - 141,844
RPS	255.59	254.67	250.27	235.64	198.71	209.43	208.41	203.57	184.40	167.13	157.16	142.57	6.44%
YoY %	0.36%	1.76%	6.21%	18.58%	-5.12%	0.49%	2.38%	10.40%	10.33%	6.34%	10.23%	-	-
Horiz. %	179.27%	178.63%	175.54%	165.28%	139.38%	146.90%	146.18%	142.79%	129.34%	117.23%	110.23%	100.00%	-
EPS	19.28	20.20	26.31	24.30	10.70	15.49	16.22	21.40	14.37	19.45	20.42	11.63	9.48%
YoY %	-4.55%	-23.22%	8.27%	127.10%	-30.92%	-4.50%	-24.21%	48.92%	-26.12%	-4.75%	75.58%	-	-
Horiz. %	165.78%	173.69%	226.23%	208.94%	92.00%	133.19%	139.47%	184.01%	123.56%	167.24%	175.58%	100.00%	-
DPS	14.67	11.00	10.00	7.95	7.88	7.94	8.36	6.82	8.19	7.60	6.13	6.09	5.66%
YoY %	33.36%	10.00%	25.79%	0.89%	-0.76%	-5.02%	22.58%	-16.73%	7.76%	23.98%	0.66%	-	-
Horiz. %	240.89%	180.62%	164.20%	130.54%	129.39%	130.38%	137.27%	111.99%	134.48%	124.79%	100.66%	100.00%	-
NAPS	2.84	2.84	2.7896	2.6246	2.4232	2.4104	2.3126	2.2226	2.0436	1.9368	1.8111	1.6596	5.93%
YoY %	0.00%	1.81%	6.29%	8.31%	0.53%	4.23%	4.05%	8.76%	5.51%	6.94%	9.13%	-	-
Horiz. %	171.13%	171.13%	168.09%	158.15%	146.01%	145.24%	139.35%	133.92%	123.14%	116.70%	109.13%	100.00%	-

	AQR	T4Q	31/12/23	31/12/22	31/12/21	31/12/20	31/12/19	31/12/18	31/12/17	31/12/16	31/12/15	31/12/14	CAGR
Price Multiplier on Financial Quarter End Date
Date	30/09/24	30/09/24	29/12/23	30/12/22	31/12/21	31/12/20	31/12/19	31/12/18	29/12/17	30/12/16	31/12/15	31/12/14	-
Price	2.40	2.40	2.30	2.55	1.93	2.28	2.33	2.75	2.69	1.91	2.48	1.30	-
P/RPS	0.94	0.94	0.92	1.08	0.96	1.08	1.10	1.32	1.41	1.09	1.49	0.85	0.88%
YoY %	0.00%	2.17%	-14.81%	12.50%	-11.11%	-1.82%	-16.67%	-6.38%	29.36%	-26.85%	75.29%	-	-
Horiz. %	110.59%	110.59%	108.24%	127.06%	112.94%	127.06%	129.41%	155.29%	165.88%	128.24%	175.29%	100.00%	-
P/EPS	12.45	11.88	8.74	10.43	17.76	14.60	14.13	12.53	18.05	9.32	11.45	10.48	-1.99%
YoY %	4.80%	35.93%	-16.20%	-41.27%	21.64%	3.33%	12.77%	-30.58%	93.67%	-18.60%	9.26%	-	-
Horiz. %	118.80%	113.36%	83.40%	99.52%	169.47%	139.31%	134.83%	119.56%	172.23%	88.93%	109.26%	100.00%	-
EY	8.03	8.42	11.44	9.58	5.63	6.85	7.08	7.98	5.54	10.73	8.73	9.54	2.03%
YoY %	-4.63%	-26.40%	19.42%	70.16%	-17.81%	-3.25%	-11.28%	44.04%	-48.37%	22.91%	-8.49%	-	-
Horiz. %	84.17%	88.26%	119.92%	100.42%	59.01%	71.80%	74.21%	83.65%	58.07%	112.47%	91.51%	100.00%	-
DY	6.11	4.58	4.35	3.14	4.15	3.51	3.65	2.55	3.16	4.19	2.62	5.00	-1.53%
YoY %	33.41%	5.29%	38.54%	-24.34%	18.23%	-3.84%	43.14%	-19.30%	-24.58%	59.92%	-47.60%	-	-
Horiz. %	122.20%	91.60%	87.00%	62.80%	83.00%	70.20%	73.00%	51.00%	63.20%	83.80%	52.40%	100.00%	-
P/NAPS	0.85	0.85	0.82	0.97	0.78	0.94	0.99	1.21	1.27	0.94	1.29	0.73	1.29%
YoY %	0.00%	3.66%	-15.46%	24.36%	-17.02%	-5.05%	-18.18%	-4.72%	35.11%	-27.13%	76.71%	-	-
Horiz. %	116.44%	116.44%	112.33%	132.88%	106.85%	128.77%	135.62%	165.75%	173.97%	128.77%	176.71%	100.00%	-

	AQR	T4Q	31/12/23	31/12/22	31/12/21	31/12/20	31/12/19	31/12/18	31/12/17	31/12/16	31/12/15	31/12/14	CAGR
Price Multiplier on Announcement Date
Date	22/11/24	22/11/24	27/02/24	27/02/23	25/02/22	25/02/21	25/02/20	26/02/19	28/02/18	22/02/17	26/02/16	27/02/15	-
Price	2.27	2.27	2.38	2.92	1.93	2.16	2.21	2.88	2.52	2.09	2.61	1.50	-
P/RPS	0.89	0.89	0.95	1.23	0.96	1.02	1.04	1.38	1.32	1.19	1.57	0.99	-0.45%
YoY %	0.00%	-6.32%	-22.76%	28.12%	-5.88%	-1.92%	-24.64%	4.55%	10.92%	-24.20%	58.59%	-	-
Horiz. %	89.90%	89.90%	95.96%	124.24%	96.97%	103.03%	105.05%	139.39%	133.33%	120.20%	158.59%	100.00%	-
P/EPS	11.78	11.24	9.05	11.95	17.76	13.83	13.41	13.12	16.91	10.20	12.06	12.10	-3.17%
YoY %	4.80%	24.20%	-24.27%	-32.71%	28.42%	3.13%	2.21%	-22.41%	65.78%	-15.42%	-0.33%	-	-
Horiz. %	97.36%	92.89%	74.79%	98.76%	146.78%	114.30%	110.83%	108.43%	139.75%	84.30%	99.67%	100.00%	-
EY	8.49	8.90	11.05	8.37	5.63	7.23	7.46	7.62	5.92	9.80	8.30	8.27	3.27%
YoY %	-4.61%	-19.46%	32.02%	48.67%	-22.13%	-3.08%	-2.10%	28.72%	-39.59%	18.07%	0.36%	-	-
Horiz. %	102.66%	107.62%	133.62%	101.21%	68.08%	87.42%	90.21%	92.14%	71.58%	118.50%	100.36%	100.00%	-
DY	6.46	4.85	4.20	2.74	4.15	3.70	3.85	2.43	3.37	3.83	2.49	4.33	-0.33%
YoY %	33.20%	15.48%	53.28%	-33.98%	12.16%	-3.90%	58.44%	-27.89%	-12.01%	53.82%	-42.49%	-	-
Horiz. %	149.19%	112.01%	97.00%	63.28%	95.84%	85.45%	88.91%	56.12%	77.83%	88.45%	57.51%	100.00%	-
P/NAPS	0.80	0.80	0.85	1.11	0.78	0.89	0.94	1.26	1.19	1.02	1.36	0.85	0.00%
YoY %	0.00%	-5.88%	-23.42%	42.31%	-12.36%	-5.32%	-25.40%	5.88%	16.67%	-25.00%	60.00%	-	-
Horiz. %	94.12%	94.12%	100.00%	130.59%	91.76%	104.71%	110.59%	148.24%	140.00%	120.00%	160.00%	100.00%	-

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions

6 people like this. Showing 50 of 2,090 comments

UnicornP

Agreed with csan. Undervalued and going to be more undervalued!

2022-09-15 15:09

UnicornP

Creeping up

2022-10-31 10:32

wallstreetrookie

Buy-side has no more idea. They will pump all the healthcare stocks remaining

2022-11-04 11:22

wallstreetrookie

Just look at all the non-glove companies. They are all green

2022-11-04 11:22

UnicornP

Gross got up a bit, still good. Confident prospect.

2022-11-22 19:32

UnicornP

csan sell call

2022-12-01 16:40

Lightofheaven

Yes. Yes. Yes
Hold until next year Autumn for great harvest

2022-12-05 09:57

Lightofheaven

Y.S.P remain strong and healthy..all the way towards 2023

2022-12-12 16:23

Lightofheaven

walao ehh..wat happen to YSP
Suddenly surge to fly so high today!! Happy Happy

2022-12-13 12:48

Thkent91

Finally this share has released it's true potential power. I have been waiting years for it to shine

2023-01-03 19:55

wallstreetrookieNEW

Apex Healthcare + YSP + Kotra Industries = Dream Healthcare Portfolio 2023

2023-02-23 16:34

wallstreetrookieNEW

All in

2023-02-23 16:34

pang72

QR gostan?
So, largely pump and dump for HEALTHCARE recently

2023-02-27 19:11

value_seeker

Is the breakout sustainable?

2023-02-27 20:41

hhhiii123

What happen to the price when qtr result so good, any insider news?

2023-02-28 21:35

Nighelanghelo

someone keyed in 2.49 instead of 2.94?

2023-03-01 13:36

Integrity. Intelligent. Industrious. 3iii (iiinvestsmart)$â¬Â£Â¥

Security LastPr PE DY% Divcts ROE ttm-marg
YSPSAH (Pharmaceuticals) 2.35 9.63 3.4 8 9.25 10.3

2023-03-30 17:12

Lightofheaven

hold this for long term
hold this for dividen

2023-08-01 12:25

katara

good counter

2023-08-03 16:43

katara

no one interested?💙

2024-01-05 14:18

donald770

Qr result best ever. Should be due for upside rerating!!!

2024-05-22 15:53

BullishMarket

New Production line is started to be operated for the newly acquired factory premise. With the newly operated production line, the company's Revenue YoY % growth will be significantly increased within 2 years.

2024-05-22 18:51

Papayashot

Hi BullishMarket, from where you aware that New Production line is started to be operated for the newly acquired factory premise?

2024-05-22 20:15

SincereStock

bought a few at 2.85, acceptable bargain I think considering today open at RM3

2024-05-23 11:41

katara

mid term TP 330-450

2024-05-23 12:15

katara

today steady at 295😘

2024-05-23 16:34

katara

going to fly .. .. ..

2024-05-27 21:15

SincereStock

https://www.facebook.com/xngyuan/videos/828026755888524?idorvanity=3251240861803724

chenjian sifu commented YSPSAH positively

2024-06-03 22:07

TiffanixLVxHermes

reasons to buy:
1. recorded highest revenue and profit in 20years
2. organic growth, hold patents (expect to continue deliver good result)
3. DY 3.5% above RM0.11 ex 24/6/24

let's monitor
😎

2024-06-04 15:45

xiaoeh

Dear TLVH
may i know your entry price...?

2024-06-04 16:02

TiffanixLVxHermes

above 2.90 😎

2024-06-04 16:07

xiaoeh

Noted and Thanks for your sharing👍

2024-06-04 16:12

Up_down

Yspsah has been all the while being the lowest valuation company against its peers like Ahealth & Dpharma.

2024-06-06 10:44

katara

next monday 11 sen ex😍

2024-06-19 16:35

katara

https://www.cw.com.tw/article/5064201

2024-07-04 13:55

katara

https://www.youtube.com/watch?v=lII_oVFIun0

2024-07-04 13:56

katara

https://www.ctee.com.tw/news/20220714700772-439801
永信東南亞控股是台灣本土學名藥製藥廠中，第一家跨國上市的公司。這兩年，受疫情影響，年營收成長仍有3％〜5％。即將來臨的後疫情時代，李芳信預計，自2022年起，公司營收至少有雙位數以上的成長。

2024-07-04 13:57

SincereStock

waiting for reinvestent of dividend fund on 22 july 2024

2024-07-12 15:35

Learner68

Coming QR, looking forward for its new record high revenue and PBT...

2024-08-13 12:46

Learner68

Disappointing QR. Looking forward for 2nd half performance then.

2024-08-20 18:34

SincereStock

sold all YSPSAH at open price of 2.35 after very disaapointing QR (9.00am, 21 august 2024)

2024-08-21 09:15

katara

fundamental will support share price at around 2.50 b4 next Q...

2024-08-21 09:55

Learner68

For the first half of 2024, the Group's revenue rose 5.5% to RM184.8 million compared to RM175.2 million reported in the same period last year. The Group's profit before tax for 1H24 declined 17.0% to RM26.0 million from RM31.3 million in 1H23 due to higher unrealised foreign exchange loss was recorded resulted from strengthening of US Dollar.
Therefore, does that mean the stronger ringgit is in favour of YSP?

2024-08-21 14:51

katara

For the first half of 2023, the Group recorded a profit before tax of RM31.3 million compared to RM24.4 million in the same period last year mainly due to higher sales
from domestic and overseas market and foreign exchange gain resulted from weakening of the Ringgit against the US Dollar.
--Q2 2023😁

2024-08-23 15:13

Learner68

Katara, thanks! I guess it depends on the mix/geography of the sales. Anyway, good to see seriously buyback this round by Lees.

2024-09-06 12:41

Papayashot

Q32024 quarter report: foreign exchange loss or (gain): (12,511)... This indicates 12 million of forex gain? But in their comments, they mentioned forex loss. The edge also mentioned 12 million forex loss.. (https://theedgemalaysia.com/node/734404)

Kinda confusing. Any comments guys?

1 month ago

Likesung

Other expenses are increased a lot .

1 month ago

Papayashot

In page 2 of 3QQR-2024, they indicate 12 million of forex gain.. Quite confusing.. Dunno it is typo or what

1 month ago

Likesung

Yup, they make a correction on QR so u can study again

4 weeks ago

katara

any good news..?

2 weeks ago

Featured Posts

MQ Trader

Introducing MY's First IPO Fund for Sophisticated Investors!

MQ Chat

New Update. Discover investment communities that resonate with your ideas

MQ Trader

M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a

Latest Videos